Boomerang Ventures Portfolio Company Respiratory Health Technologies Secures Seed Capital to Accelerate Growth in Respiratory Wellness

Aims to Disrupt $11B Wellness and Respiratory Health Market INDIANAPOLIS, IN / ACCESS Newswire / October 9, 2025 / Boomerang Ventures today announced that portfolio company Respiratory Health ...
Business Wire

New Study Explores Nalmefene and Naloxone for Reversal of Respiratory Depression Induced by Fentanyl in a Clinical Opioid Induced Respiratory Depression Model

STAMFORD, Conn.--(BUSINESS WIRE)--Purdue Pharma L.P. (“Purdue”) today announced The Journal of Clinical Pharmacology has published findings from a study in healthy adult volunteers that demonstrated ...